ARCHIVES

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

Alan Rabson Named NCI Deputy Director

August 11, 1995

Funding Opportunities. (8-page issue).

May 2, 2003

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004